Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:

“The production of our second issue of AI in Precision Oncology  is well underway and promises to deliver an array of significant papers very soon. I’m excited to preview some of these papers online this week, including a personal editorial reflecting on the tremendous strides we’ve made in oncology over the past two decades.

This journey, marked by both heartache and hope, showcases a pivotal shift towards precision medicine and the integration of AI, setting a new (and exciting) trajectory for our ongoing battle against cancer. I am eager to share these insights with you and immensely grateful for the unwavering support from our community. Together, we stand on the brink of unprecedented progress, committed to learning and advancing in our fight against cancer.

Thank you all for joining me on this journey.”

Source: Douglas Flora/LinkedIn